GlassScriptPhysician profile
Hung Nyun Kim
NPI 1215936364
$11,380.19
in general payments reported to CMS, 2019-2025
12 companies · $11K in 2025
The $11K reported for 2025 was more than what 97% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2021: $211 · 2022: $157 · 2023: $151 · 2024: $95.98 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,402.00 |
| Food and Beverage | $368.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $10,402.00 | 2025 | Arikayce |
| Med-El Corporation | $190.20 | 2019-2022 | |
| Medtronic, INC. | $139.67 | 2021 | |
| Acclarent, INC | $124.03 | 2019 | |
| Oticon Medical, LLC | $94.96 | 2019-2021 | |
| Genzyme Corporation | $92.37 | 2023 | |
| Integra Lifesciences Corporation | $65.38 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Advanced Bionics, LLC | $65.18 | 2022-2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Glaxosmithkline, LLC. | $59.29 | 2024 | Nucala |
| Davol INC. | $58.90 | 2023 | Arista Ah Flexitip |
| Stryker Corporation | $53.08 | 2021-2024 | Audion Et Dilation System, Core |
| Depuy Synthes Sales INC. | $35.13 | 2025 | Trumatch, Matrixmandible |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hung Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.